文献速递糖尿病

长期1型糖尿病患者的胰高血糖素与GLP-1分泌异常:残余C肽的影响

Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide.
PubMed 文献 · Diabetologia · 2019-01-06

研究纳入29例15岁后起病的1型糖尿病成人及4例新发对照,行混合餐耐量试验,按超敏C肽峰值>30 pmol/l定义胰岛素微分泌。结果显示长期1型糖尿病患者胰高血糖素反应不受残余β细胞影响,而GLP-1反应随C肽阳性显著降低,且C肽阳性者GLP-1与胰高血糖素相关。

要点

  • 长期1型糖尿病中残余C肽未减弱混合餐后胰高血糖素反应
  • C肽阳性者GLP-1反应显著低于C肽阴性者
  • C肽阳性者GLP-1与胰高血糖素水平显著相关

核心结论

  • 长期1型糖尿病患者混合餐后胰高血糖素反应不因残余β细胞存在而降低。
  • 残余C肽水平与GLP-1反应降低相关,提示特定调控通路。

研究设计与样本

  • 成人1型糖尿病起病年龄>15岁者29例,过夜空腹后行液体混合餐耐量试验。
  • 超敏法C肽峰值>30 pmol/l定义为胰岛素微分泌。
  • 另纳入4例新发1型糖尿病作为对照。

主要发现

  • C肽阳性长期糖尿病者(n=9)与C肽阴性者(n=16)及新发者(n=4)的胰高血糖素和GLP-1峰值、Δ0-max及AUC相当。
  • 平均胰高血糖素水平组间差异有统计学意义(p=0.01)。
  • 按C肽阳性状态,平均GLP-1反应显著降低(p<0.001,ANOVA)。
  • C肽阳性长期糖尿病者中GLP-1与胰高血糖素相关(Pearson r=0.915,p=0.004),新发者中亦相关(p<0.001),C肽阴性者中无相关。

关键数值与推荐

  • 胰岛素微分泌定义为超敏法C肽峰值>30 pmol/l。
  • 胰高血糖素平均水平组间比较p=0.01。
  • GLP-1平均反应按C肽阳性比较p<0.001(ANOVA)。
  • C肽阳性长期糖尿病者GLP-1与胰高血糖素相关Pearson r=0.915,p=0.004。

临床怎么用

  • 评估长期1型糖尿病患者残余β细胞时,需注意其胰高血糖素反应未必减弱。
  • 残余C肽阳性者GLP-1反应降低,解读肠促胰素相关指标时应考虑C肽状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Recent studies have demonstrated that residual beta cells may be present in some people with long-standing type 1 diabetes, but little is known about the potential impact of this finding on alpha cell function and incretin levels. This study aimed to evaluate whether insulin microsecretion could modulate glucagon and glucagon-like peptide-1 (GLP-1) responses to a mixed meal tolerance test (MMTT). METHODS: Adults with type 1 diabetes onset after the age of 15 years (n = 29) underwent a liquid MMTT after an overnight fast. Insulin microsecretion was defined when peak C-peptide levels were >30 pmol/l using an ultrasensitive assay. Four individuals with recent-onset type 1 diabetes were included as controls. Glucagon and GLP-1 responses were analysed according to C-peptide patterns. RESULTS: We found comparable peak values, Δ0-max levels and AUCs of glucagon and GLP-1 responses in C-peptide-positive participants (n = 9) and C-peptide-negative participants (n = 16) with long-standing diabetes and in participants with recent-onset diabetes (n = 4). Mean glucagon levels, however, differed (p = 0.01). Mean GLP-1 responses were significantly lower according to C-peptide positivity (p < 0.001, ANOVA). Interestingly, GLP-1 levels correlated to glucagon values in C-peptide-positive participants with long-standing diabetes (Pearson's r = 0.915, p = 0.004) and in participants with recent-onset diabetes (p < 0.001) but not in C-peptide-negative participants. CONCLUSIONS/INTERPRETATION: The glucagon response to an MMTT in people with long-standing type 1 diabetes is not reduced by the presence of residual beta cells. The reduction of GLP-1 responses according to residual C-peptide levels suggests specific regulatory pathways.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Thivolet C, Marchand L, Chikh K, et al. Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide. Diabetologia. 2019. PMID: 30612138. doi:10.1007/s00125-018-4804-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。